FDA Drug Class II — Moderate

MIDAZOLAM HYDROCHLORIDE INJECTION, 5 mg/1 mL, C-IV, For IM or IV Use, 2 mL Vials, Rx only. APP Pharmaceuticals, LLC. Schaumburg, IL 60173. NDC: 63323-412-25.

Hazard

Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.

Products

MIDAZOLAM HYDROCHLORIDE INJECTION, 5 mg/1 mL, C-IV, For IM or IV Use, 2 mL Vials, Rx only. APP Pharmaceuticals, LLC. Schaumburg, IL 60173. NDC: 63323-412-25.
Brand
Fresenius Kabi USA, LLC
UPC
Lot 6003827, Exp. Date 04/2015

Units Affected

101,200 Vials